Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 422.60B | 427.67B | 433.85B | 377.30B | 334.79B | 328.36B |
Gross Profit | 168.13B | 170.67B | 159.82B | 142.48B | 130.80B | 125.22B |
EBITDA | 19.92B | 17.98B | 26.28B | 18.85B | 17.02B | 14.37B |
Net Income | 8.04B | 4.54B | 10.90B | 5.68B | 5.99B | -752.00M |
Balance Sheet | ||||||
Total Assets | 257.78B | 252.81B | 231.13B | 201.80B | 174.38B | 169.74B |
Cash, Cash Equivalents and Short-Term Investments | 56.46B | 60.09B | 54.98B | 44.29B | 45.60B | 51.87B |
Total Debt | 96.81B | 118.05B | 98.79B | 80.21B | 59.07B | 52.13B |
Total Liabilities | 165.19B | 162.34B | 143.78B | 124.59B | 97.18B | 96.76B |
Stockholders Equity | 92.53B | 90.40B | 87.31B | 77.21B | 77.19B | 72.98B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -3.11B | 151.00M | -3.38B | -12.25B | 5.25B |
Operating Cash Flow | 0.00 | 8.01B | 9.30B | 4.28B | -5.73B | 12.43B |
Investing Cash Flow | 0.00 | -12.49B | -10.40B | -9.59B | -6.69B | -8.22B |
Financing Cash Flow | 0.00 | 10.78B | 12.40B | 3.94B | 5.59B | 14.68B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
70 Outperform | ¥23.67B | 10.24 | 4.47% | 11.38% | 10.55% | ||
66 Neutral | ¥11.49B | 12.05 | 3.59% | 4.17% | 28.46% | ||
66 Neutral | £1.85B | 11.50 | 6.20% | 3.01% | 0.63% | -17.57% | |
65 Neutral | ¥43.49B | 15.70 | 0.22% | 22.50% | 20.53% | ||
59 Neutral | ¥12.18B | ― | 3.48% | 1.15% | -14869.21% | ||
58 Neutral | ¥61.39B | 13.52 | 2.19% | -1.42% | -58.51% |